← FDA Drug Approvals (Drugs@FDA)

TRI-ESTARYLLA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2013-01-30

Drug application

FDA Application #

ANDA090793

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRI-ESTARYLLA

Generic name

NORGESTIMATE AND ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORGESTIMATE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

Xiromed, LLC.

First approval

2013-01-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown